Clinical Trials Logo

Clinical Trial Summary

The study objectives of this projects are to examine the hypothesis that the sympathetic and blood pressure responses to exercise will be attenuated during and after heat exposure in patients with peripheral artery disease, via altering the sensitivity of the muscle afferent receptors.


Clinical Trial Description

Peripheral arterial disease (PAD) affects 8-12 million Americans and its cardinal symptom is leg pain during exercise, termed "intermittent claudication". The diagnosis of PAD involves measuring the ankle-brachial index (ABI, i.e. the systolic pressure in the ankle divided by the systolic pressure in the arm); values below 0.9 are indicative of large vessel obstruction. Intermittent claudication is the most common symptom of this disease and it regularly occurs during exercise/physical activity but is relieved promptly by rest. Previous studies suggest that as the exercise pressor reflex is activated in patients with PAD, BP and heart rate (HR) are exaggerated. The BP rises during walking in the PAD patients were significantly greater than that seen in healthy control subjects. A recent human study from our group further indicates that an early BP response occurred during plantar flexion exercise before claudication was noted by the subjects, which may suggest that the accentuated BP response was due to an augmented muscle mechanoreflex in PAD. Moreover, another recent study from our group also showed that PAD patients have augmented renal vasoconstriction during plantar flexion exercise. It has been shown that exercise has benefits for patients with PAD. However, exercise becomes limited due to the pain and fatigue associated with the disease. Moreover, the augmented pressor response to exercise in PAD may increase the risk for the end organ damage (e.g. brain and/or heart). Thus, finding alternate/complimentary interventions that modulate the cardiovascular system and autonomic nervous system, and can be tolerated by the patients, would be beneficial. One possible intervention is heat exposure, since acute bouts of exercise and acute heat exposure have similar acute effects on both the autonomic and cardiovascular systems. For example, both exercise and heat exposure increase body temperature, increase HR, increase cardiac output (CO), increase left ventricular ejection fraction (EF), and enhance myocardial function. In the peripheral circulation, both exercise and heat exposure increase limb blood flow , muscle blood flow, and skin blood flow. Moreover, recent studies suggest that whole body exposure improves the endothelium function in PAD patients (e.g. activates endothelial progenitor cells CD34+). However, the effect of heat treatment on the ability of walking of PAD patients has not been examined. Moreover, it is unknown if heating can normalize/decrease the accentuated the pressor responses to exercise in PAD patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03900832
Study type Interventional
Source Milton S. Hershey Medical Center
Contact Jian Cui, PhD
Phone 7175311799
Email jcui@pennstatehealth.psu.edu
Status Recruiting
Phase Early Phase 1
Start date May 15, 2019
Completion date July 2025

See also
  Status Clinical Trial Phase
Completed NCT03157531 - Safety and Effectiveness of B-Laserâ„¢ in Subjects Affected With Infrainguinal PAD N/A
Recruiting NCT03668353 - Recombinant SeV-hFGF2/dF Injection for PAOD Phase 1
Not yet recruiting NCT04108806 - Study of Peripheral Arterial Calcification N/A
Completed NCT02561299 - Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee (BTK) Lesions - A Pilot Study N/A
Completed NCT01355406 - Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent System N/A
Recruiting NCT06239493 - IVUS-Guided Treatment for Percutaneous Vascular Interventions
Active, not recruiting NCT00390767 - Safety Study of MultiGeneAngio in Patients With Peripheral Arterial Disease (PAD) Phase 1/Phase 2
Completed NCT02907203 - Clinical Investigation of the GORE® Drug-Coated PTA Balloon Catheter (GORE® DCB Catheter)
Recruiting NCT03686228 - Treatment of No-option CLI by G-CSF-mobilized PB-MNC N/A
Recruiting NCT03683628 - Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC N/A
Active, not recruiting NCT04204564 - VISION and VQI Paclitaxel Safety Analysis
Terminated NCT01341340 - The ABSORB BTK (Below The Knee) Clinical Investigation N/A
Completed NCT03135535 - Micro-mobile Foot Compression and Diabetic Foot Phase 2
Completed NCT03452293 - SUPERa Stenting After SUBintimal Crossing of TASC C-D Femoro-popliteal Lesions in CLI Patients
Recruiting NCT05361967 - Tack Optimized Balloon Angioplasty Post-Market Study
Active, not recruiting NCT02500303 - Influence of Diabetes on Lower Limb Amputation N/A
Completed NCT03358355 - Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial Phase 1/Phase 2
Withdrawn NCT03516383 - Pulse Wave Velocity Imaging in the Assessment of PAD
Completed NCT03590769 - Arterial Imaging of Inflammation and Resolution After Endovascular Surgery Phase 1
Completed NCT01938391 - Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal N/A